Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients

The aim of the study was to investigate the safety of adenosine 5'-triphosphate (ATP) administration at home in pre-terminal cancer patients. Included were patients with cancer for whom medical treatment options were restricted to supportive care, who had a life expectancy of less than 6 months...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigational new drugs 2007-12, Vol.25 (6), p.571-579
Hauptverfasser:	Beijer, Sandra, Gielisse, Eric A R, Hupperets, Pierre S, van den Borne, Ben E E M, van den Beuken-van Everdingen, Marieke, Nijziel, Marten R, van Henten, Arjen M J, Dagnelie, Pieter C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Adenosine triphosphatase Adenosine Triphosphate - administration & dosage Adenosine Triphosphate - adverse effects Adenosine Triphosphate - therapeutic use Aged Aged, 80 and over Angina pectoris Anorexia Cancer Cancer therapies Clinical trials Drug dosages Dyspnea Dyspnea - chemically induced Electrocardiography Enzymes Fatigue - etiology Fatigue - prevention & control Female Home health care Home Infusion Therapy Hospitals Humans Infusions, Intravenous Internal medicine Ischemia Life expectancy Lung cancer Male Maximum Tolerated Dose Middle Aged Neoplasms - mortality Neoplasms - physiopathology Oncology Pain Palliative care Palliative Care - methods Patient safety Patients Phase III Studies Pulmonology Terminal Care - methods Toxicity Weight Loss - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!